Intestine as the Exclusive Site of Distant Metastasis From Lung Adenocarcinoma Detected on 18 F-FDG PET/CT.

Clin Nucl MedAug 13, 2026 (epub)

Liqin Zhu, LiJun Peng, Fucen Liu et al.

✦ AI-curated · Sources linked

Case in brief

A 77-year-old man with lung adenocarcinoma underwent 18F-FDG PET/CT, which showed a moderately hypermetabolic pulmonary nodule and two intensely hypermetabolic intestinal lesions. Immunohistochemistry confirmed that the intestinal lesions were metastases from the pulmonary adenocarcinoma. The intestine was the exclusive site of distant metastasis. PET/CT also identified an ascending colon lesion, helping guide clinical management.

What made this case unusual

The intestinal lesions were the exclusive distant metastases, an uncommon pattern that can be mistaken for a primary gastrointestinal tumor.

Diagnostic / clinical pearl

In a patient with lung adenocarcinoma, intestinal lesions may represent metastases even when no other distant metastatic sites are identified; immunohistochemistry can establish their origin.

Why it matters

Whole-body 18F-FDG PET/CT can reveal additional intestinal lesions and help define the extent and origin of disease for clinical management.

Source

Published in Clin Nucl Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.